Date: October 22, 2017 @ 3:00 pm – @ 4:40 pm
Location: Hanqi Investment Inc. 1633 Bayshore Hwy, Burlingame, CA 94010
About the Topic:
Do you know that more than 30 of the world's leading biopharmaceutical companies are leveraging Singapore as a key home base to drive innovation, commercialization and market growth in Asia? Do you know that the vibrant biopharmaceutical market in Singapore is propelled not only by innovation but also it's pro-business environment, low labor costs and corporate tax rate, and strong government support? Come find out more about the business and tax landscape in Singapore for the biotechnology and pharmaceutical industry, hosted by one of the BIG FOUR business accounting firms PwC.
The workshop will look at Singapore's business environment and touch on its pharma and biotech scene.
We will also talk about the following:
- Possible business structures;
- Entry options;
- Tax environment as well as tax incentives and grants available.
Limited free space for early registration. Please register as soon as possible.
Partner, Tax Market Leader and Pharmaceutical & Life Sciences Leader
Abhijit is a an International Tax Partner and Pharmaceutical & Healthcare practice leader in Corporate Tax Advisory Services Group of PwC Singapore. Abhijit has more than 27 years of experience in advising and managing various cross-border complex business structures and operational models for MNCs and SMEs as they expand globally.
LENG Harn Szuan
Director, Corporate Tax and Stamp Duty
Harn Szuan is a director with PwC Singapore’s Corporate Tax Advisory team and has more than 14 years of corporate and international tax experience. In 2015, Harn Szuan spent the year at the Los Angeles office of PwC US under a joint programme between PwC and a Singapore government economic agency where she focused on developing opportunities with companies keen to invest in Singapore.
Singapore PWC – $0 (USD) - 9 left